How does Johnson & Johnson's COVID-19 vaccine compare to Moderna, Pfizer?
Fox News
With Johnson & Johnson’s COVID-19 vaccine facing an FDA-recommended pause after several instances of severe blood clots were reported in recipients, those who had scheduled J&J shots could see a bumpy rescheduling process involving canceled or delayed appointments, or even find themselves lined up to receive alternatives if supply allows.
Vaccines developed by Moderna and Pfizer-BioNTech operate on a newer platform with mRNA, or messenger RNA, technology, while Johnson & Johnson’s candidate involves a more traditional modified adenovirus vector vaccine with a durable protein exterior encasing the DNA, lending itself to a longer shelf-life. Clinical trials indicated vaccines developed by Pfizer and Moderna were about 95% effective against symptomatic illness, and Johnson & Johnson’s candidate had a 66.3% efficacy. Trial data also revealed all three vaccines were highly effective in preventing hospitalizations and deaths.
Sparkly holiday clothing can trigger extra screening at airport security checkpoints, says the TSA, as 8.03 million Americans prepare to fly during peak holiday travel season.
A federal judge struck down a California policy on Monday that prohibited school staff from revealing a student's gender identity to their families.
A passenger etiquette debate has erupted online over airplane seating policies after viral posts show cramped seats. Users remain divided over responsibility during flights.
New research highlights certain spices and foods with potential health benefits: chili peppers, black cumin, saffron, rosemary and sage, and kimchi. Here's why.
New Android Sound Notifications feature helps users detect important sounds like smoke alarms through visual alerts. Kurt CyberGuy Knutsson explains how it works.
Brown University shooting victims Mukhammad Aziz Umurzokov and Ella Cook remembered after suspected gunman Claudio Manuel Neves-Valente found dead in storage unit.
Georgetown University reportedly removed U.N. expert Francesca Albanese, who is facing U.S. sanctions, from its list of affiliated scholars.
New research from China reveals cancer patients who receive immunotherapy before 3 p.m. show significantly better survival rates than those treated later.
The Trevi Fountain will charge tourists about $2.35 in admission fees starting in February 2026 as Rome tackles crowds of up to 70,000 daily at the historic site.
New study finds that microplastics could double multiple sclerosis risk, according to Uppsala University research analyzing blood samples from 1,800 Swedish individuals.
The holiday season's most popular Christmas attractions across America also receive thousands of complaints on Tripadvisor — with visitors citing long waits and high prices.
Brown University's board of trustees, including Bank of America CEO Brian Moynihan, remains silent after campus murders that killed two students and led to criticism.
Cybersecurity expert reveals how to spot fake Netflix suspension emails by checking account directly, avoiding email links and using two-factor authentication.